跳到主要內容

臺灣博碩士論文加值系統

(216.73.216.26) 您好!臺灣時間:2026/10/22 14:09
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:劉雅菁
研究生(外文):Ya-Ging Liu
論文名稱:過表現錳型超氧歧化酶減緩Thioacetamide誘導斑馬魚胚胎類心臟衰竭併發症
論文名稱(外文):Overexpression of Manganese Superoxide Dismutase Prevent Thioacetamide Induced Heart Failure Like Syndrome During Zebrafish Development
指導教授:耿全福
指導教授(外文):Chuian - Fu Ken
學位類別:碩士
校院名稱:國立彰化師範大學
系所名稱:生物技術研究所
學門:生命科學學門
學類:生物科技學類
論文種類:學術論文
論文出版年:2013
畢業學年度:101
語文別:中文
論文頁數:111
中文關鍵詞:錳型超氧歧化酶、心臟衰竭、肥大細胞、活性氧分子
外文關鍵詞:Mn-SOD、Heart Failure、Mast cells、oxidative damage
相關次數:
  • 被引用被引用:0
  • 點閱點閱:214
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:1
Thioacetamide (TAA)已證實可透過活性氧分子造成斑馬魚胚胎發育時期心包膜水腫(edema in pericardial sac;eps),體節畸型甚至死亡等現象,其細胞與分子機制須進一步驗證,且是否可藉由過表現人類錳型超氧歧化酶(manganese superoxide dismutase ;Mn-SOD) 抑制TAA所造成的胚胎氧化傷害亦值得進一步研究。首先我們探討TAA影響胚胎發育的哪個時期造成eps 的產生?結果發現從胚胎受精後14 hpf 開始處理32 mM TAA至36 hpf,結果造成心臟跳動速率變慢50-60%,以及心臟狹窄細長的畸型,這些症狀類似心臟衰竭(Heart Failure;HF) ,且也觀察到eps的現象。接著利用轉基因技術建立活體肝臟專一性即時動態分析活性氧分子(ROS) 的模式斑馬魚,結果證實TAA可促進胚胎內superoxide及H2O2大量產生,並且經由誘導TNF- α的表現,使SOD 活性被抑制。我們利用Tol2轉位子系統建立肝臟專一性過表現Mn-SOD的轉基因魚,其mRNA 表現增加約2倍,蛋白質表現增加約3倍,且活性增加約1.3-1.5倍。轉基因魚F1世代胚胎經32mM TAA處理後,結果發現TNF- α表現量降低為1.5倍,而SOD 的活性也回復。再來我們利用免疫組織化學方法,以anti-human MC tryptase 為抗體,結果再次證實TAA造成胚胎心包膜附近聚集許多已活化的肥大細胞,若過表現Mn-SOD則可見到Mast cells聚集在心包膜附近的數量減少,且蛋白質氧化傷害也減少大約4倍,eps 的發生機率也降低到10 ~ 20%,最後胚胎的死亡率也顯著降低。我們的研究結果表明,TAA誘導胚胎發育過程中eps 的形成是由於增強ROS的產生和誘發Mast cell活化。若過表現人類Mn-SOD能降低細胞內ROS和氧化損傷,以及抑制Mast cell活化,且抑制TAA誘導的eps形成。
Thioacetamide (TAA) is a hepatotoxin that can cause hepatocellular carcinoma in mice and zebrafish, but little is known about its toxic effect on embryonic development. In the previous study, we have showed TAA can enhanced ROS generation and induced the edema in pericardial sac (eps) formation, but the cellular mechanism was still unclear. In this study, we try to identify the cells which involved in TAA induced eps formation, and overexpression of manganese superoxide dismutase (Mn-SOD) to reduce eps formation in TAA treatment. First, we test that the toxicological mechanism of TAA on eps formation, and we treated with 32mM TAA of zebrafish embryos between 14 –36 hpf. The result show the heart beat rate 50-60%, and a narrow elongated heart malformations, these symptoms similar to heart failure, and also observed eps formation. We use of transgenic technology to build real-time in vivo dynamic analysis of ROS in liver specificity at zebrafish model, the results confirm the embryo can promote superoxide and H2O2 generated after 32 mM TAA treatment, and 32 mM TAA treatment zebrafish embryos can induction of TNF-α highly expressed and the SOD activity was inhibited. Overexpress Mn-SOD transgenic fish by Tol2 transposon system were generated and confirmed by RT-PCR, Western blotting and enzyme activity assay. The result obviously show the Mn-SOD mRNA expression increased approximately 2 fold, protein expression increased approximately 3 fold, and the activity increased approximately 1.3-1.5 fold. The transgenic F1 transgenic fish embryos were treated with TAA, the results showed that TNF-α expression is reduced to 1.5 fold, and the activity can rescue of SOD. We use antibody of anti-human MC tryptase to Immunohistochemistry, we found the mast cells were congregate and degranulate at the pericardial sac, and overexpression of Mn-SOD decrease amount of the mast cells in the pericardial sac in the number and protein oxidative damage is reduced by approximately 4 fold, the eps formation rate was reduced to about 10-20%. Our results showed TAA induced eps/heart failure-like syndrome are due to enhanced ROS generation, and induced mast cells activation during embryonic development. To overexpress Mn-SOD can reduce intracellular ROS, Mast cells numbers, and oxidative damages, and can partially rescue TAA induced embryo toxicity.
中文摘要 I
English Abstract III
誌謝 V
縮寫表 VI
目錄 VII
第一章 、前言 1
第一節、肝毒性物質硫代乙醯胺 (Thioacetamide, TAA) 1
1-1-1. TAA的介紹 1
1-1-2. TAA導致肝癌的機制 2
1-1-3. TAA對於胚胎的影響 3
第二節、心臟衰竭 (Heart Failure) 4
1-2-1. 心臟衰竭的介紹及原因 4
1-2-2. 心臟衰竭的疾病分級 5
第三節、TAA造成Mast Cell活化形成edema in pericardial sac (eps) 6
第四節、活性氧分子 (ROS) 在生物體的調控 7
1-4-1. 活性氧分子及自由基介紹 7
1-4-2. 抗氧化防禦機制 8
第五節、錳型超氧歧化酶 (Manganese Superoxide Dismutase;Mn-SOD) 9
1-5-1. 錳型超氧歧化酶之介紹 9
1-5-2. 錳型超氧歧化酶之基因組成與調節方面的研究 9
1-5-3. 錳型超氧歧化酶基因的剔除與心臟疾病的關係 10
1-5-4. TAA 影響抗氧化酵素的活性 10
第六節、活體內(in vivo)偵測ROS的系統 10
1-6-1. 活體內(in vivo)偵測粒線體Superoxide的系統 10
1-6-2. 活體內(in vivo)偵測Hydrogen peroxide的系統 12
第七節、研究動機 13
第二章、實驗材料 14
2-1. 材料 14
2-2. 載體 14
2-2-1. 選殖載體 (Cloning vector) 14
2-2-2.表現載體 (Expression vector ) 14
2-3. 宿主 ( host ) 14
2-4. 培養基 ( 含抗生素 ) 14
2-4-1. 液態 Luria-Bertani (LB) 15
2-4-2. Luria-Bertani (LB) Agar medium(固態) 15
2-5. 抗生素 15
2-6. DNA marker 15
2-7. DNA 內染劑 15
2-8. Protein marker 16
2-9. 5×蛋白質樣品染劑 (5×Protein staining sample dye) 16
2-10. SDS-PAGE 緩衝溶液 16
2-11. 蛋白質染色劑與退染劑 17
2-12. 溶液 17
2-13. 抗體與轉漬膜 17
2-14. Kit 組 18
2-15. 實驗藥品 20
2-16. 實驗儀器及設備 21
2-17. primer sequences 22
第三章、實驗步驟 25
3-1藥物處理斑馬魚胚胎 25
3-1-1. 斑馬魚飼養與孵魚準備 25
3-1-2. TAA處理Wild Type斑馬魚胚胎及BMP4:EGFP基因轉殖魚胚胎 25
3-2基因選殖人類Mn-SOD 、Mito.-cpYFP 及roGFP2-Orp1 25
3-2-1. 重組人類Mn-SOD的質體 25
3-2-2. 重組人類Mito.-cpYFP的質體 29
3-3 顯微注射 (Microinjection) 35
3-3-1. 斑馬魚飼養與孵魚準備 35
3-3-2. Microinjection 拉針與磨針之製備 35
3-3-3. Microinjection Plate之製備 36
3-3-4. Microinjection Tol2 transposase mRNA之合成製備 36
3-3-5. Human Mn-SOD、Mito.-cpYFP 、roGFP2-Orp1表現載體之顯微注射 37
3-4. 萃取 Genomic DNA 38
3-5 Reverse Transcriptase PCR ( RT-PCR ) 39
3-5-1. RNA之萃取 39
3-5-2. 反轉錄酶反應(Reverse Transcriptase, RT) 39
3-6 西方點漬法( Western blot) 40
3-6-1. 蛋白質電泳製備 40
3-6-2. 蛋白質製備 41
3-6-3. 蛋白質定量 42
3-6-4. 西方點漬法 42
3-7 Mast Cell Tryptase Immunohistochemistry 43
3-7-1. 斑馬魚飼養與孵魚準備 43
3-7-2. Thioacetamide ( TAA ) 處理 43
3-7-3. 組織包埋 43
3-7-4. 組織切片 44
3-7-5. Immunohistochemistry 44
3-8 Whole Mount In situ Hybridization 45
3-8-1. 勝任細胞的製備與轉型作用 45
3-8-2. 抽取微量質體 46
3-8-3. 確認質體 46
3-8-4. 探針合成 46
3-8-5. 胚胎前處理 48
3-8-6. 前處理 48
3-8-7. 探針雜交及清洗 49
3-8-8. 抗體雜交及呈色 50
3-8-9. 固定及退染 50
3-9 細胞內分子氧化程度測定 51
3-9-1. L-012 Assay 51
3-9-2. DCFH-DA Assay 51
3-10細胞內分子氧化傷害測定 52
3-10-1. protein carbonyl 分析 52
3-11 細胞內Superoxide Dismutase (SOD) 活性測定 53
3-11-1. SOD標準曲線(Superoxide Dismutase (SOD) standard curve) 53
3-11-2.細胞內SOD活性測定 54
第四章 、結果 55
第一節、TAA 影響胚胎發育的時間點分析 55
第二節、TAA誘導類心臟衰竭症狀 (Heart Failure like syndrome;HF) 56
第三節、 TAA造成心包膜水腫 (edema in pericardial sac;eps) 是經由Mast Cell活化引起的 57
第四節、建立活體內(in vivo)偵測ROS的系統以確定TAA誘導胚胎內產生ROS 58
4-4-1. 建立mito-cpYFP 基因轉殖魚 58
4-4-2. 建立roGFP2-Orp1 基因轉殖魚 59
第五節、過表現人類錳型超氧歧化酶 (Human Manganese Superoxide Dismutase;H-MnSOD) 減緩TAA所造成的胚胎毒性 60
4-5-1. 建立H-MnSOD基因轉殖魚 60
第六節、 TAA誘導胚胎TNF-α大量表現抑制抗氧化酵素SOD的活性 61
第七節、過表現H-MnSOD 抑制Mast Cells 活化及減緩eps 發生的機率 62
第八節、 過表現H-MnSOD 抑制TAA導致的氧化傷害 63
第九節、 過表現H-MnSOD 抑制TAA誘導仔魚死亡 63
第十節、 結論 64
第五章 討論 65
第一節、肝毒性物質TAA對Wild type 斑馬魚胚胎造成Edema in pericardial sac (eps) 之分析 65
5-1-1. TAA對Wild type 斑馬魚胚胎型態與發育時間點之影響 65
5-1-2. TAA誘發心臟衰竭併發症 66
5-1-3. TAA 誘導Mast Cells聚集在pericardial sac造成eps之分析 67
5-1-4. TAA 對Wild type 斑馬魚胚胎誘導ROS 之分析 68
第二節、人類錳型超氧歧化酵素(Human Manganese Superoxide Dismutase;H-MnSOD)之基因選殖 69
第三節、TAA 對Mn-SOD轉基因魚胚胎的Tumor necrosis factor alpha (TNF-α) mRNA 表現量的影響 70
第四節、TAA 對Mn-SOD轉基因魚胚胎的SOD 抗氧化酵素活性的影響 71
第五節、TAA 對Mn-SOD轉基因魚胚胎的Mast cell聚集在pericardial sac造成eps之分析 72
第六節、TAA 對Mn-SOD轉基因魚胚胎內的氧化傷害的影響 72
第七節、TAA 對Mn-SOD轉基因魚胚胎的eps 發生率及致死率之影響 73
第八節 未來展望 74
第六章、參考文獻 75
第七章、圖表 82
第八章、附錄 107

圖目錄
圖1、TAA 影響胚胎發育的時間點分析...82
圖2、TAA 影響斑馬魚胚胎的心跳速率.83
圖3、TAA影響斑馬魚胚胎心臟的型態.84
圖4、TAA影響BMP4:EGFP基因轉殖魚心臟的型態 86
圖5、TAA活化肥大細胞(Mast cells) 聚集在心包膜(pericardial sac) 附近 87
圖6、構築mito-cpYFP的基因轉殖魚 .88
圖7、mito-cpYFP基因轉殖魚的表現 .89
圖8、mito-cpYFP基因轉殖魚可以偵測Superoxide 90
圖9、構築roGFP2-Orp1 的基因轉殖魚 91
圖10、roGFP2-Orp1基因轉殖魚的表現 92
圖11、roGFP2-Orp1 基因轉殖魚可以偵測Hydrogen Peroxide 93
圖12、構築人類錳型超氧歧化酶(H-MnSOD) 的基因轉殖 94
圖13、人類錳型基因超氧歧化酶(H-MnSOD) 基因轉殖魚的表現 95
圖14、在組織專一性表現H-MnSOD 的基因轉殖魚 96
圖15、分析H-MnSOD 基因轉殖魚之SOD的活性 97
圖16、原位雜交(whole mount in situ hybridization) 分析在0-120 小時之前H-MnSOD 基因轉殖魚之基因分布情形 98
圖17、過表現H-MnSOD 可抑制TNF- α 的mRNA 表現量 99
圖18、過量表現H-MnSOD 可補救TAA 抑制SOD的活性 100
圖19、過表現H-MnSOD 抑制TAA活化Mast cells聚集在pericardial sac.102
圖20、過表現H-MnSOD減緩eps 發生的機率 103
圖21、過表現H-MnSOD抑制TAA導致的蛋白質過氧化 104
圖22、過表現H-MnSOD 抑制TAA誘導仔魚死亡 105
圖23、過表現錳型超氧歧化酶減緩Thioacetamide誘導斑馬魚胚胎類心臟衰竭併發症 106
Abraham, S.N., and John, A.L.S. (2010). Mast cell-orchestrated immunity to pathogens. Nature Reviews Immunology 10, 440-452.
Amann, R., Schuligoi, R., Lanz, I., and Donnerer, J. (1995). Histamine-induced edema in the rat paw--effect of capsaicin denervation and a CGRP receptor antagonist. European journal of pharmacology 279, 227-231.
Andrés, D., Sánchez-Reus, I., Bautista, M., and Cascales, M.a. (2003). Depletion of Kupffer cell function by gadolinium chloride attenuates thioacetamide-induced hepatotoxicity: expression of metallothionein and HSP70. Biochemical pharmacology 66, 917-926.
Bissonnette, E., Enciso, J., and Befus, A. (1995). Inhibition of tumour necrosis factor‐alpha (TNF‐α) release from mast cells by the anti‐inflammatory drugs, sodium cromoglycate and nedocromil sodium. Clinical &; Experimental Immunology 102, 78-84.
Borgstahl, G.E., Parge, H.E., Hickey, M.J., Beyer Jr, W.F., Hallewell, R.A., and Tainer, J.A. (1992). The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles. Cell 71, 107-118.
Caporali, A., Sala-Newby, G., Meloni, M., Graiani, G., Pani, E., Cristofaro, B., Newby, A., Madeddu, P., and Emanueli, C. (2007). Identification of the prosurvival activity of nerve growth factor on cardiac myocytes. Cell Death &; Differentiation 15, 299-311.
Chilakapati, J., Korrapati, M.C., Hill, R.A., Warbritton, A., Latendresse, J.R., and Mehendale, H.M. (2007). Toxicokinetics and toxicity of thioacetamide sulfoxide: a metabolite of thioacetamide. Toxicology 230, 105-116.
Chilakapati, J., Shankar, K., Korrapati, M.C., Hill, R.A., and Mehendale, H.M. (2005). Saturation toxicokinetics of thioacetamide: role in initiation of liver injury. Drug metabolism and disposition 33, 1877-1885.
Childs, J., and Siegler, E. (1945). Compounds for control of orange decays. Science 102, 68.
Church, S.L., Grant, J.W., Meese, E.U., and Trent, J.M. (1992). Sublocalization of the gene encoding manganese superoxide dismutase (MnSOD/SOD2) to 6q25 by fluorescence in situ hybridization and somatic cell hybrid mapping.
D'Autreaux, B., and Toledano, M.B. (2007). ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8, 813-824.
Díez-Fernández, C., Sanz, N., and Cascales, M. (1996). Intracellular calcium concentration impairment in hepatocytes from thioacetamide-treated rats. Implications for the activity of Ca 2+ dependent enzymes.
Journal of hepatology 24, 460-467.
Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J.J., Ponikowski, P., Poole-Wilson, P.A., Strömberg, A., van Veldhuisen, D.J., Atar, D., and Hoes, A.W. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European heart journal 29, 2388-2442.
Ding, Z., and Zhuo, L. (2013). Attenuation of hepatic fibrosis by an imidazolium salt in thioacetamide‐induced mouse model. Journal of gastroenterology and hepatology 28, 188-201.
Dobson, J.T., Seibert, J., Teh, E.M., Da'as, S., Fraser, R.B., Paw, B.H., Lin, T.J., and Berman, J.N. (2008). Carboxypeptidase A5 identifies a novel mast cell lineage in the zebrafish providing new insight into mast cell fate determination. Blood 112, 2969-2972.
Dryer, S.E., Dryer, R., and Autor, A. (1980). Enhancement of mitochondrial, cyanide-resistant superoxide dismutase in the livers of rats treated with 2, 4-dinitrophenol. Journal of Biological Chemistry 255, 1054-1057.
Dyroff, M.C., and Neal, R.A. (1981). Identification of the major protein adduct formed in rat liver after thioacetamide administration. Cancer research 41, 3430-3435.
Ekman, I., Lundman, B., and Norberg, A. (1999). The meaning of hospital care, as narrated by elderly patients with chronic heart failure. Heart &; Lung: The Journal of Acute and Critical Care 28, 203-209.
Fitzhugh, O.G., and Nelson, A.A. (1948). Liver tumors in rats fed thiourea or thioacetamide. Science 108, 626-628.
Fleischmann, K.E., Beckman, J.A., Buller, C.E., Calkins, H., Fleisher, L.A., Freeman, W.K., Froehlich, J.B., Kasper, E.K., Kersten, J.R., and Robb, J.F. (2009). 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 120, 2123-2151.
Fridovich, I. (1995). Superoxide radical and superoxide dismutases. Annu Rev Biochem 64, 97-112.
Fujii, J., and Taniguchi, N. (1991). Phorbol ester induces manganese-superoxide dismutase in tumor necrosis factor-resistant cells. Journal of Biological Chemistry 266, 23142-23146.
Genestra, M. (2007). Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal 19, 1807-1819.
Grega, G.J., Kline, R.L., Dobbins, D.E., and Haddy, F. (1972). Mechanisms of edema formation by histamine administered locally into canine forelimbs. American Journal of Physiology--Legacy Content 223, 1165-1171.
Gu, K., Zhao, J.D., Ren, Z.G., Ma, N.Y., Lai, S.T., Wang, J., Liu, J., and Jiang, G.L. (2011). A natural process of cirrhosis resolution and deceleration of liver regeneration after thioacetamide withdrawal in a rat model. Mol Biol Rep 38, 1687-1696.
Gutscher, M., Sobotta, M.C., Wabnitz, G.H., Ballikaya, S., Meyer, A.J., Samstag, Y., and Dick, T.P. (2009). Proximity-based protein thiol oxidation by H2O2-scavenging peroxidases. Journal of Biological Chemistry 284, 31532-31540.
Hajovsky, H., Hu, G., Koen, Y., Sarma, D., Cui, W., Moore, D.S., Staudinger, J.L., and Hanzlik, R.P. (2012). Metabolism and toxicity of thioacetamide and thioacetamide S-oxide in rat hepatocytes. Chemical Research in Toxicology 25, 1955-1963.
Halliwell, B., and Gutteridge, J. (1984). Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet 1, 1396.
Huang, C.-c., Chen, P.-C., Huang, C.-W., and Yu, J. (2007). Aristolochic acid induces heart failure in zebrafish embryos that is mediated by inflammation. Toxicological sciences 100, 486-494.
Hunter, A., Holscher, M., and Neal, R. (1977). Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system. Journal of Pharmacology and Experimental Therapeutics 200, 439-448.
Kawakami, K. (2007). Tol2: a versatile gene transfer vector in vertebrates. Genome Biol 8, S7.
Keele, B.B., McCord, J., and Fridovich, I. (1971). Further characterization of bovine superoxide dismutase and its isolation from bovine heart. Journal of Biological Chemistry 246, 2875-2880.
Ken, C.-F., Lin, C.-T., Shaw, J.-F., and Wu, J.-L. (2003). Characterization of fish Cu/Zn–superoxide dismutase and its protection from oxidative stress. Marine Biotechnology 5, 167-173.
Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., and Schilling, T.F. (1995). Stages of embryonic development of the zebrafish. Developmental dynamics 203, 253-310.
Kirkpatrick, J.N., Vannan, M.A., Narula, J., and Lang, R.M. (2007). Echocardiography in Heart FailureApplications, Utility, and New Horizons. Journal of the American College of Cardiology 50, 381-396.
Kwak, K.-G., Wang, J.-H., Shin, J.-W., Lee, D.-S., and Son, C.-G. (2011a). A traditional formula, Chunggan extract, attenuates thioacetamide-induced hepatofibrosis via GSH system in rats. Human &; experimental toxicology 30, 1322-1332.
Kwak, K.G., Wang, J.H., Shin, J.W., Lee, D.S., and Son, C.G. (2011b). A traditional formula, Chunggan extract, attenuates thioacetamide-induced hepatofibrosis via GSH system in rats. Human &; experimental toxicology 30, 1322-1332.
Lebovitz, R.M., Zhang, H., Vogel, H., Cartwright Jr, J., Dionne, L., Lu, N., Huang, S., and Matzuk, M.M. (1996). Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proceedings of the National Academy of Sciences 93, 9782-9787.
Lee, J.W., Shin, K.D., Lee, M., Kim, E.J., Han, S.-S., Han, M.Y., Ha, H., Jeong, T.C., and Koh, W.S. (2003). Role of metabolism by flavin-containing monooxygenase in thioacetamide-induced immunosuppression. Toxicology letters 136, 163-172.
Lee, K.S., Kim, S.R., Park, S.J., Park, H.S., Min, K.H., Lee, M.H., Jin, S.M., Jin, G.Y., Yoo, W.H., and Lee, Y.C. (2006). Hydrogen peroxide induces vascular permeability via regulation of vascular endothelial growth factor. American journal of respiratory cell and molecular biology 35, 190-197.
Li, Y., Huang, T.-T., Carlson, E.J., Melov, S., Ursell, P.C., Olson, J.L., Noble, L.J., Yoshimura, M.P., Berger, C., and Chan, P.H. (1995). Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature genetics 11, 376-381.
Liu, S.-Q., Yu, J.-P., Chen, H.-L., Luo, H.-S., Chen, S.-M., and Yu, H.-G. (2006). Therapeutic effects and molecular mechanisms of Ginkgo biloba extract on liver fibrosis in rats. The American journal of Chinese medicine 34, 99-114.
Ma, Z., Zhang, Y., Huet, P., and Lee, S.S. (1999). Differential effects of jaundice and cirrhosis on β-adrenoceptor signaling in three rat models of cirrhotic cardiomyopathy. Journal of hepatology 30, 485-491.
Mangipudy, R.S., Chanda, S., and Mehendale, H.M. (1995). Tissue repair response as a function of dose in thioacetamide hepatotoxicity. Environmental health perspectives 103, 260.
Marieb, E.N., and Hoehn, K. (2007). Human anatomy &; physiology (Pearson Education).
Masuda, A., Longo, D., Kobayashi, Y., Appella, E., Oppenheim, J., and Matsushima, K. (1988). Induction of mitochondrial manganese superoxide dismutase by interleukin 1. The FASEB journal 2, 3087-3091.
Matsunaga, Y., and Terada, T. (2000). Mast cell subpopulations in chronic inflammatory hepatobiliary diseases. Liver 20, 152-156.
Mattiussi, M., Tilman, G., Lenglez, S., and Decottignies, A. (2012). Human telomerase represses ROS-dependent cellular responses to Tumor Necrosis Factor-α without affecting NF-κB activation. Cellular signalling 24, 708-717.
McMurray, J.J. (2010). Systolic heart failure. New England Journal of Medicine 362, 228-238.
Metcalfe, D.D., Baram, D., and Mekori, Y.A. (1997). Mast cells. Physiological reviews 77, 1033-1079.
Morgan, B., Sobotta, M.C., and Dick, T.P. (2011). Measuring E sub GSH and H2O2 with roGFP2-based redox probes. Free Radical Biology and Medicine 51, 1943-1951.
Motoori, S., Majima, H.J., Ebara, M., Kato, H., Hirai, F., Kakinuma, S., Yamaguchi, C., Ozawa, T., Nagano, T., and Tsujii, H. (2001). Overexpression of mitochondrial manganese superoxide dismutase protects against radiation-induced cell death in the human hepatocellular carcinoma cell line HLE. Cancer research 61, 5382-5388.
Oakley, F.D., Abbott, D., Li, Q., and Engelhardt, J.F. (2009). Signaling components of redox active endosomes: the redoxosomes. Antioxid Redox Signal 11, 1313-1333.
Reid, T.M., and Loeb, L.A. (1993). Effect of DNA-repair enzymes on mutagenesis by oxygen free radicals. Mutat Res 289, 181-186.
Rekha, R.D., Amali, A.A., Her, G.M., Yeh, Y.H., Gong, H.-Y., Hu, S.-Y., Lin, G.-H., and Wu, J.-L. (2008). Thioacetamide accelerates steatohepatitis, cirrhosis and HCC by expressing HCV core protein in transgenic zebrafish Danio rerio. Toxicology 243, 11-22.
Rhee, S.G. (2006). Cell signaling. H2O2, a necessary evil for cell signaling. Science 312, 1882-1883.
Salama, S.M., Abdulla, M.A., AlRashdi, A.S., Ismael, S., Alkiyumi, S.S., and Golbabapour, S. (2013). Hepatoprotective effect of ethanolic extract of Curcuma longa on thioacetamide induced liver cirrhosis in rats. BMC complementary and alternative medicine 13, 56.
Sanz, N., Dı́ez-Fernández, C., Andrés, D., and Cascales, M.a. (2002). Hepatotoxicity and aging: endogenous antioxidant systems in hepatocytes from 2-, 6-, 12-, 18-and 30-month-old rats following a necrogenic dose of thioacetamide. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1587, 12-20.
Scandalios, J. (2005a). Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Brazilian Journal of Medical and Biological Research 38, 995-1014.
Scandalios, J.G. (2005b). Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz J Med Biol Res 38, 995-1014.
Sekar, Y. (2011). Protein Tyrosine Nitration in Mast Cells (University of Alberta).
Shapiro, H., Ashkenazi, M., Weizman, N., Shahmurov, M., Aeed, H., and Bruck, R. (2006). Curcumin ameliorates acute thioacetamide‐induced hepatotoxicity. Journal of gastroenterology and hepatology 21, 358-366.
Shin, T.-Y., Kim, S.-H., Choi, C.-H., Shin, H.-Y., and Kim, H.-M. (2004). Isodon japonicus decreases immediate-type allergic reaction and tumor necrosis factor-α production. International archives of allergy and immunology 135, 17-23.
Sohn, H.-Y., Gloe, T., Keller, M., Schoenafinger, K., and Pohl, U. (1999). Sensitive superoxide detection in vascular cells by the new chemiluminescence dye L-012. Journal of vascular research 36, 456-464.
Staňková, P., Kučera, O., Lotková, H., Roušar, T., Endlicher, R., and Červinková, Z. (2010). The toxic effect of thioacetamide on rat liver in vitro. Toxicology in vitro 24, 2097-2103.
Stone, K.D., Prussin, C., and Metcalfe, D.D. (2010). IgE, mast cells, basophils, and eosinophils. Journal of Allergy and Clinical Immunology 125, S73-S80.
Swedberg, K., Cleland, J., Dargie, H., Drexler, H., Follath, F., Komajda, M., Tavazzi, L., Smiseth, O.A., Gavazzi, A., and Haverich, A. (2005). Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005) The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. European heart journal 26, 1115-1140.
Tsuchiya, T., Wang, L., Yafune, A., Kimura, M., Ohishi, T., Suzuki, K., Mitsumori, K., and Shibutani, M. (2012). Disruptive cell cycle regulation involving epigenetic downregulation of Cd kn2a(p16 Ink4a) in early-stage liver tumor-promotion facilitating liver cell regeneration in rats.
Uehara, T., Hirode, M., Ono, A., Kiyosawa, N., Omura, K., Shimizu, T., Mizukawa, Y., Miyagishima, T., Nagao, T., and Urushidani, T. (2008). A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats. Toxicology 250, 15-26.
Wallace, D.C. (2001). A mitochondrial paradigm for degenerative diseases and ageing. Novartis Found Symp 235, 247-263; discussion 263-246.
WAN, X.S., DEVALARAJA, M.N., and ST. CLAIR, D.K. (1994). Molecular structure and organization of the human manganese superoxide dismutase gene. DNA and Cell Biology 13, 1127-1136.
Wang, T., Shankar, K., Ronis, M.J.J., and Mehendale, H.M. (2000). Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1. Journal of Pharmacology and Experimental Therapeutics 294, 473-479.
Wang, W., Fang, H., Groom, L., Cheng, A., Zhang, W., Liu, J., Wang, X., Li, K., Han, P., Zheng, M., et al. (2008). Superoxide flashes in single mitochondria. Cell 134, 279-290.
Weisiger, R.A., and Fridovich, I. (1973). Superoxide dismutase organelle specificity. Journal of Biological Chemistry 248, 3582-3592.
Wiseman, H., and Halliwell, B. (1996). Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochemical Journal 313, 17.
Wong, G., and Goeddel, D.V. (1988). Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242, 941-944.
Woo, H.A., Yim, S.H., Shin, D.H., Kang, D., Yu, D.Y., and Rhee, S.G. Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling. Cell 140, 517-528.
Xu, D., Rovira, II, and Finkel, T. (2002). Oxidants painting the cysteine chapel: redox regulation of PTPs. Dev Cell 2, 251-252.
Zaragoza, A., Andrés, D., Sarrión, D., and Cascales, M.a. (2000). Potentiation of thioacetamide hepatotoxicity by phenobarbital pretreatment in rats. Inducibility of FAD monooxygenase system and age effect. Chemico-biological interactions 124, 87-101.
王嘉蓉, 抗氧化酵素拮抗Thioacetamide 與HCV core protein 在斑馬魚早期胚胎早期發育中所誘導的氧化壓力. 國立彰化師範大學生物技術研究 所碩士論文, 2011.
江柏蓉, Thioacetamide誘導斑馬魚胚胎心包膜腫大的細胞與分子機制的探 討. 國立彰化師範大學生物技術研究所碩士論文, 2011.

連結至畢業學校之論文網頁點我開啟連結
註: 此連結為研究生畢業學校所提供,不一定有電子全文可供下載,若連結有誤,請點選上方之〝勘誤回報〞功能,我們會盡快修正,謝謝!
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top